ALSO READStrides Shasun intimates of successful USFDA inspection of Cuddalore manufacturing facility Strides Shasun intimates of successful USFDA inspection of API facility at Puducherry Vivimed Labs intimates of successful USFDA inspection of its API facility in Spain Alembic Pharmaceuticals intimates of successful inspection of its Baroda facility Dr Reddys Laboratories intimates of successful inspection of its formulations Srikakulum Plant Unit II
At TalojaAlkem Laboratories announced that US FDA had conducted an inspection at the Company's Bioequivalence facility located at Taloja, India from 10 July, 2017 to 14 July, 2017. At the end of the inspection, no Form 483 was issued.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)